ANNOVIS BIO INC's ticker is ANVS and the CUSIP is 03615A108. A total of 30 filers reported holding ANNOVIS BIO INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $326,209 | -33.6% | 34,374 | 0.0% | 0.11% | -29.6% |
| Q2 2023 | $491,204 | -4.5% | 34,374 | +3.0% | 0.16% | -6.4% |
| Q1 2023 | $514,293 | +17.9% | 33,374 | +2.8% | 0.17% | +10.9% |
| Q4 2022 | $436,126 | -2.0% | 32,474 | 0.0% | 0.16% | -6.6% |
| Q3 2022 | $445,000 | +45.4% | 32,474 | +20.4% | 0.17% | +59.0% |
| Q2 2022 | $306,000 | +20.9% | 26,974 | +42.2% | 0.10% | +45.8% |
| Q1 2022 | $253,000 | -0.4% | 18,974 | +31.1% | 0.07% | 0.0% |
| Q4 2021 | $254,000 | -44.8% | 14,474 | 0.0% | 0.07% | -47.4% |
| Q3 2021 | $460,000 | -73.9% | 14,474 | -29.6% | 0.14% | -73.4% |
| Q2 2021 | $1,761,000 | +99.2% | 20,574 | -35.1% | 0.52% | +80.7% |
| Q1 2021 | $884,000 | +132.0% | 31,678 | -37.4% | 0.28% | +120.9% |
| Q4 2020 | $381,000 | +55.5% | 50,588 | -0.9% | 0.13% | +37.2% |
| Q3 2020 | $245,000 | – | 51,038 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 463,797 | $3,497,000 | 1.42% |
| Worth Venture Partners, LLC | 119,538 | $901,000 | 0.71% |
| Lokken Investment Group LLC | 32,211 | $243,000 | 0.22% |
| Sterling Investment Advisors, Ltd. | 50,588 | $381,000 | 0.13% |
| Modera Wealth Management, LLC | 43,846 | $331,000 | 0.03% |
| Cannell & Co. | 10,000 | $75,000 | 0.00% |
| Sowell Financial Services LLC | 1,529 | $12,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MORGAN STANLEY | 14,286 | $108,000 | 0.00% |
| BROWN ADVISORY INC | 14,942 | $113,000 | 0.00% |